Stratification Biomarkers of MCI Conversion

TMT®MS3 Quantitative Proteomics

Goal – Identify plasma biomarkers that predict the conversion from mild cognitive impairment to Alzheimer’s disease within 12 months

Outcome – A panel of 10 plasma proteins showed changes in abundance that could predict patients with early conversion to AD with potential application in patient stratification for clinical trial enrolment.

Collaborators Institute of Psychiatry, Kings College London and University of Oxford

View all case studies